Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for OPY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for OPY and 80,000+ other tickers.
See exactly how OPY's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OPY and 80,000+ other tickers.
Headquartered in New York since its founding in 1881, Oppenheimer Holdings Inc. serves as a prominent middle-market investment bank and full-service broker-dealer, extending its operations across the Americas, Europe, the Middle East, and Asia. The company provides a comprehensive suite of financial services to a diverse clientele, including affluent individuals, corporate executives, public and private enterprises, institutions, governmental bodies, financial sponsors, and investors globally. Its extensive brokerage offerings cover a wide range of assets, from exchange-traded and…
Analyst opinions and sales projections for weight loss and type 2 diabetes drug VK2735 vary widely, reflecting both promise and uncertainty. VK2735's potential as a dual therapy could drive significant market share gains.
FuelCell Energy Inc. (NASDAQ:FCEL) shares are trading higher Tuesday morning as Wall Street initiated coverage with an aggressive price target tied to accelerating AI data center power demand.
Microsoft Corp. (NASDAQ:MSFT) remained in focus Monday as investors weighed broader market pressure against the company's push to turn Copilot into a larger workplace platform and revenue engine.
- Oppenheimer Initiates a Robust Process with Global Reach for the Benefit of Shareholders - - Oppenheimer Initiates a Robust Process with Global Reach for the Benefit of Shareholders -
The co-founder and chairman of the Seattle fintech giant was inducted into the Ivy League school's Entrepreneur Hall of Fame, which honors alumni who have made lasting positive impacts through their ventures.